Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV vaccine booster dose trial in kidney transplant recipients with low anti-HBs titers
TCTR20261008002Phase 3Not yet recruiting
- Sponsor
- Jackrapong Bruminhent
- Start
- Jan 2027
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Jackrapong Bruminhent. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on TCTR20261008002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261008002.